Prehospital intraosseous administration of a fibrinolytic agent in a patient with ST-elevation acute coronary syndrome: a case report
Abstract
The safety and efficacy of prehospital intraosseous administration of nonimmunogenic staphylokinase in a patient with ST-elevation acute coronary syndrome (STE-ACS) was clinically confirmed. A case of prehospital intraosseous thrombolytic therapy with non-immunogenic staphylokinase at a single bolus dose of 15 mg in a patient with STE-ACS is described. Intraosseous administration is a rapid and reliable emergency, which can be used, among other things, for thrombolytic therapy.
Fields of Study & Subjects
Acute Myocardial Infarction Research
Acute Ischemic Stroke Management
Cardiac Arrest and Resuscitation
Publication details
- Journal / source
- Russian Journal of Cardiology
- Volume
- 30
- Issue
- 12
- Pages
- 6664–6664
- Publication date
- 18 January 2026